Business
Zika Virus Suspected To Be Transmitted Sexually; Premier Biomedical Inc. Increases Focus; Optimistic Their Patented Extracorporeal Methodology Could Be Most Effective Treatment
Zika Virus Suspected To Be Transmitted Sexually; Premier Biomedical Inc. Increases Focus; Optimistic Their Patented Extracorporeal Methodology Could Be Most Effective Treatment.
About this update from Premier Biomedical Inc
[{"type":"text","content":"\n \n Premier Biomedical, Inc. (OTCQB: \n BIEI) a biotech research public company focused on discovering, \n developing, and commercializing medical treatments for a wide range of \n diseases in humans, noted that the CDC reported recently, via \n CNN, that sexual transmission of the Zika Virus has been identified \n in 14 additional cases. As a result of this information, Premier \n Biomedical is considering their priorities to investigate accelerated \n development of their patented extra-corporeal (outside the body) process \n in an effort to generate an effective treatment for the Zika virus. The \n envisioned treatment is a variation of their patented process, initially \n developed to treat viruses like AIDS and Ebola.\n \n \n William A. Hartman, President and CEO, indicated, “Premier’s \n extracorporeal process has the distinct advantage that allows us to \n physically remove the Zika virus, which could eliminate dangerous \n side-effects associated with standard medical treatments.”\n \n \n About Premier Biomedical, Inc.\n \n \n Premier Biomedical, Inc. is a research-based company that intends to \n discover and develop medical treatments for a wide range of diseases in \n humans, initially targeting the treatment of cancer. The Company's \n common stock trades on the Over-The-Counter Bulletin Board under the \n ticker symbol \"BIEI.\" http://www.premierbiomedical.com/\n \n \n Safe Harbor Notice\n \n \n Certain statements contained herein are “forward-looking statements” (as \n defined in the Private Securities Litigation Reform Act of 1995). \n Premier Biomedical, Inc. cautions that statements, and assumptions made \n in this news release constitute forward-looking statements and makes no \n guarantee of future performance. Forward-looking statements are based on \n estimates and opinions of management at the time statements are made. \n These statements may address issues that involve significant risks, \n uncertainties, estimates made by management. Actual results could differ \n materially from current projections or implied results. Premier \n Biomedical, Inc. undertakes no obligation to revise these statements \n following the date of this news release.\n \n View source version on businesswire.com: http://www.businesswire.com/news/home/20160225005892/en/","length":3854,"tagName":"div"}]